Amit Dutt

Last updated

Amit Dutt
Amit Dutt pic.jpg
Born (1973-09-06) 6 September 1973 (age 50)
Patna, India
Alma mater
Known forStudies on Fibroblast growth factor receptor
Awards
Scientific career
Fields
Institutions
Doctoral advisor
  • Alex Hajnal (ZU)
  • Vanga Siva Reddy (DU)
  • Arif Ali (JMI)

Amit Dutt (born 6 September 1973) is an Indian scientist, geneticist and the principal investigator at Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) of Tata Memorial Centre. Known for his studies on Fibroblast growth factor receptor, Dutt is a Wellcome Trust / DBT India Alliance Intermediate Fellow. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, for his contributions to medical sciences in 2017. [1] [note 1]

Contents

Biography

Delhi University Delhiuni.jpg
Delhi University

Amit Dutt, born on 6 September 1973 in Patna, capital of the Indian state of Bihar, earned a BSc in botany from Desbandhu College, Delhi University in 1994 and continued there to complete a post-graduate diploma in Biochemical Technology in 1995 from the Sri Venkateswara College. [2] [note 2] Moving to Jamia Millia Islamia, he obtained his MSc in 1997 and enrolled for doctoral studies at the Delhi center of the International Centre for Genetic Engineering and Biotechnology to secure a PhD in plant genetics in 2000, guided by Vanga Siva Reddy of Delhi University and Arif Ali of Jamia Millia Islamia. [3] Subsequently, he traveled to the University of Zurich and working under the guidance of Alex Hajnal at the Institute of Molecular Life Sciences of the university, secured another PhD in Developmental Biology in 2004. [4] [5]

Dutt continued in Zurich to work at the Institute of Neuropathology of the university and in 2005, he moved to join the laboratory of Matthew Meyerson at the Broad Institute of Harvard and MIT as a research associate and worked there till 2010, stationing at Dana–Farber Cancer Institute, a Harvard Medical School affiliate. [2] On his return to India in Oct 2010, he joined Tata Memorial Centre, at the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Navi Mumbai where he is the principal investigator at scientist (grade F) and heads the Integrated Cancer Genomics Lab, popularly known as Dutt Lab. [6]

Legacy and honors

Protein MMP10 PDB 1q3a Protein MMP10 PDB 1q3a.png
Protein MMP10 PDB 1q3a

Dutt is known to have made notable contributions in the field of cancer genetics, [7] widening our understanding of the disease and its translational possibilities. [8] The group led by him have been engaged in the study of the progression of cancer in the lung, breast, cervical, gallbladder, head and neck and his research may be classified under three heads; cancer genomics, functional genomics and pathogen discovery. [6] It is reported that the research collaboration Dutt had with Kumar Prabhash of Tata Memorial Centre led to the Epidermal Growth Factor Receptor (EGFR) and KRAS mutation profiling of Indian lung cancer patients for the first time. [9] The research association between the duo has also led to the development of HPVDetector and TMC-SNPdb (both computational tools) and CRE, an experimental tool. [4] Discovery of MMP10 protein, a biomarker which assists the doctors in deciding the surgical protocol in tongue cancer patients is another contribution of Dutt, which was the result of collaborative research with Sudhir Nair of TMC. [10] They also identified a genome signature which associated tobacco chewing with oral cancer. His studies have been documented by way of a number of articles [11] and ResearchGate, an online article repository of scientific articles, has listed 118 of them. [12] [note 3]

Dutt is a member of faculty of F1000 Prime and holds memberships in associations such as American Association for Cancer Research, the Indian chapter of Lung Cancer Consortium of Asia, Society of Biological Chemists (India), and Indian Association for Cancer Research. [13] He has also sat in the editorial boards of BMC Genomics and PLoS One journals. [9]

Awards and honors

Apart from a number of student fellowships, Dutt has held research fellowships, starting with the Julius Klaus Foundation Fellowship in 2004, followed by Swiss National Science Foundation Postdoctoral fellowship of the Government of Switzerland in 2005. [2] The Department of Biotechnology awarded him the Ramalingaswamy Fellowship in 2010 [9] [14] and he became a Wellcome Trust / DBT India Alliance Intermediate Fellow in 2011. [4] The Council of Scientific and Industrial Research awarded Dutt the Shanti Swarup Bhatnagar Prize, one of the highest Indian science awards in 2017. [15]

Selected bibliography

See also

Notes

  1. ↑ Long link - please select award year to see details
  2. ↑ Curriculum vitae available in downloadable format
  3. ↑ Please see Selected bibliography section

Related Research Articles

<span class="mw-page-title-main">Gefitinib</span> Medication used for cancer

Gefitinib, sold under the brand name Iressa, is a medication used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. Therefore, it is only effective in cancers with mutated and overactive EGFR, but resistances to gefitinib can arise through other mutations. It is marketed by AstraZeneca and Teva.

<span class="mw-page-title-main">Epidermal growth factor receptor</span> Transmembrane protein

The epidermal growth factor receptor is a transmembrane protein that is a receptor for members of the epidermal growth factor family of extracellular protein ligands.

<span class="mw-page-title-main">Erlotinib</span> Medication for treatment of non-small-cell lung cancer

Erlotinib, sold under the brand name Tarceva among others, is a medication used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. Specifically it is used for NSCLC with mutations in the epidermal growth factor receptor (EGFR) — either an exon 19 deletion (del19) or exon 21 (L858R) substitution mutation — which has spread to other parts of the body. It is taken by mouth.

<span class="mw-page-title-main">Non-small-cell lung cancer</span> Any type of epithelial lung cancer other than small-cell lung carcinoma

Non-small-cell lung cancer (NSCLC), or non-small-cell lung carcinoma, is any type of epithelial lung cancer other than small-cell lung cancer (SCLC). NSCLC accounts for about 85% of all lung cancers. As a class, NSCLCs are relatively insensitive to chemotherapy, compared to small-cell carcinoma. When possible, they are primarily treated by surgical resection with curative intent, although chemotherapy has been used increasingly both preoperatively and postoperatively.

<span class="mw-page-title-main">KRAS</span> Protein-coding gene in humans

KRAS is a gene that provides instructions for making a protein called K-Ras, a part of the RAS/MAPK pathway. The protein relays signals from outside the cell to the cell's nucleus. These signals instruct the cell to grow and divide (proliferate) or to mature and take on specialized functions (differentiate). It is called KRAS because it was first identified as a viral oncogene in the KirstenRAt Sarcoma virus. The oncogene identified was derived from a cellular genome, so KRAS, when found in a cellular genome, is called a proto-oncogene.

<span class="mw-page-title-main">MMP10</span> Protein-coding gene in the species Homo sapiens

Stromelysin-2 also known as matrix metalloproteinase-10 (MMP-10) or transin-2 is an enzyme that in humans is encoded by the MMP10 gene.

<span class="mw-page-title-main">Afatinib</span> Chemical compound

Afatinib, sold under the brand name Gilotrif among others, is a medication which is used to treat non-small cell lung carcinoma (NSCLC). It belongs to the tyrosine kinase inhibitor family of medications. It is taken by mouth.

<span class="mw-page-title-main">Brigatinib</span> ALK inhibitor for treatment of non-small-cell lung cancer

Brigatinib, sold under the brand name Alunbrig among others, is a small-molecule targeted cancer therapy being developed by Ariad Pharmaceuticals, Inc. Brigatinib acts as both an anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR) inhibitor.

Gopal Chandra Kundu is an Indian cell and cancer biologist and a Senior Scientist (Scientist-G) at National Centre for Cell Science. He is known for his contributions towards the understanding the mechanism of cancer progression in breast, melanoma and other cancers and development of novel therapeutic targets and target-based therapy in cancers.

<span class="mw-page-title-main">Icotinib</span> Chemical compound

Icotinib is a highly selective, first generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). Icotinib is approved for use in China as first-line monotherapy in patients with non-small-cell lung cancer with somatic EGFR mutations.

<span class="mw-page-title-main">Osimertinib</span> Chemical compound, used as a medication to treat lung cancer

Osimertinib, sold under the brand name Tagrisso, is a medication used to treat non-small-cell lung carcinomas with specific mutations. It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor.

Tathamangalam Ananthanarayanan Venkitasubramanian (1924–2003), popularly known as TAV, was an Indian biochemist, known for his researches on tuberculosis and the biochemistry of bacillus. He was a professor and the head of the department of biochemistry at Vallabhbhai Patel Chest Institute, Delhi. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, in 1968, for his contributions to biological sciences.

Debi Prasad Sarkar is an Indian biochemist, immunologist and virologist. He was the head of biochemistry department and dean FIAS, at the University of Delhi South Campus and served as the director of IISER Mohali from 2017 to 2019. He then resumed his professorship and subsequently promoted to the post of senior professor of biochemistry, with effect from 18 July 2019 at the parent institute, University of Delhi. Serving as joint director, DSSEED, IoE, University of Delhi. On the scientific front, he is renowned for his researches on Sendai virus and developing reconstituted viral envelopes. He is an elected fellow of Indian Academy of Sciences, National Academy of Sciences, India and Indian National Science Academy. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian Science Awards, in 1998, for his contributions to Biological Sciences. Received Excellence Teacher Award on service by the University of Delhi.

Shantanu Chowdhury is an Indian structural biologist and a professor at Institute of Genomics and Integrative Biology of the Council of Scientific and Industrial Research. He is known for developing a mechanism for gene regulation mediated by DNA Secondary-Structure in diverse cellular contexts. An elected fellow of the National Academy of Sciences, India, he is a recipient of the National Bioscience Award for Career Development of the Department of Biotechnology in 2010. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, in 2012, for his contributions to biological sciences.

Bhaskar Saha is an Indian immunologist, cell biologist and a senior scientist at National Centre for Cell Science, Pune. He is known for his contributions in the fields of immunology and cell signaling. He is an elected fellow of two of the major Indian science academies, National Academy of Sciences, India and Indian Academy of Sciences. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, in 2009, for his contributions to biological sciences.

Balasubramanian Gopal is an Indian structural biologist, molecular biophysicist and a professor at the Molecular Biophysics Unit of the Indian Institute of Science. He is known for his studies on cell wall synthesis in Staphylococcus aureus and is an elected fellow of the National Academy of Sciences, India, Indian National Science Academy and the Indian Academy of Sciences. He received the National Bioscience Award for Career Development of the Department of Biotechnology in 2010. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, in 2015, for his contributions to biological sciences.

Krishna Balaji Sainis is an Indian immunologist. He is a former senior professor of Life Sciences at Homi Bhabha National Institute and an elected fellow of the National Academy of Sciences, India. Since 1999, he has served as the Indian representative on the United Nations Scientific Committee on the Effects of Atomic Radiation. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology for his contributions to medical sciences in 1994.

Subrat Kumar Panda is an Indian virologist, professor and Head Department of Pathology at All India Institute of Medical Sciences, Delhi. Known for his researches in viral hepatitis, Panda is an elected fellow of the Indian Academy of Sciences, Indian National Science Academy and the National Academy of Medical Sciences. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 1995.

Anurag Agrawal is an Indian pulmonologist, medical researcher, Dean of the Trivedi School of Biosciences at Ashoka University, and the former director of the Institute of Genomics and Integrative Biology, a CSIR institution. Known for his studies on lung diseases, Agrawal has been a senior fellow of the DBT-Wellcome Trust. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 2014. He is also a recipient of the National Bioscience Award for Career Development of the Department of Biotechnology which he received in 2015 and the 2020 Sun Pharma Science Foundation award in Medical Sciences.

Amit Singh is an Indian microbiologist and an associate professor at the department of microbiology and cell biology of the Indian Institute of Science. A Wellcome-DBT Senior Fellow, Singh is known for his studies on the pathogenesis of Mycobacterium tuberculosis. The Department of Biotechnology of the Government of India awarded him the National Bioscience Award for Career Development for 2017/18. He was awarded with the prestigious CSIR- Shanti Swarup Bhatnagar award on 2021 for his phenomenal contributions in bio-scientific research. He received the 2021 Shanti Swarup Bhatnagar Prize for Science and Technology in Biological Science.

References

  1. ↑ "View Bhatnagar Awardees". Shanti Swarup Bhatnagar Prize. 11 November 2017. Retrieved 11 November 2017.
  2. 1 2 3 "Biographical Information - Amit Dutt" (PDF). ACTREC. 3 November 2017. Archived from the original (PDF) on 7 November 2017. Retrieved 3 November 2017.
  3. ↑ "Dr. Amit Dutt-Biography". ACTREC. 5 November 2017. Archived from the original on 7 November 2017. Retrieved 5 November 2017.
  4. 1 2 3 "About Fellow-Dutt". Wellcome-DBT. 5 November 2017. Retrieved 5 November 2017.
  5. ↑ "Amit Dutt, B.Sc, Ph.D., Ph.D. Principal Investigator". India Cancer Research Database. 5 November 2017. Retrieved 5 November 2017.
  6. 1 2 "Integrated Cancer Genomics Lab". ACTREC. 5 November 2017. Archived from the original on 7 November 2017. Retrieved 5 November 2017.
  7. ↑ "Brief Profile of the Awardee". Shanti Swarup Bhatnagar Prize. 21 October 2017. Retrieved 21 October 2017.
  8. ↑ "Handbook of Shanti Swarup Bhatnagar Prize Winners" (PDF). Council of Scientific and Industrial Research. 17 October 2017. Archived from the original (PDF) on 4 March 2016. Retrieved 17 October 2017.
  9. 1 2 3 "It's a Moment of Pride for Jamia Millia". Okhla Times. 1 October 2017. Retrieved 5 November 2017.
  10. ↑ Prasad, R. (23 August 2017). "Biomarker tells of tongue cancer spread". The Hindu. Retrieved 5 November 2017.
  11. ↑ "On Google Scholar". Google Scholar. 17 October 2017. Retrieved 17 October 2017.
  12. ↑ "On ResearchGate". 17 October 2017. Retrieved 17 October 2017.
  13. ↑ "F1000 Prime faculty". F1000 Prime. 5 November 2017. Retrieved 5 November 2017.
  14. ↑ "List of Fellows". Ramalingaswami Fellows. 6 November 2017. Retrieved 6 November 2017.
  15. ↑ "10 scientists receive Shanti Swarup Bhatnagar Prize". The Hindu. 26 September 2017. Retrieved 11 November 2017.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.